摘要:
Compounds of formula I: where R1, R2 and R3 are the same or different and signify hydrogens, halogens, alkyl, alkylaryl, alkyloxy, hydroxy, nitro, amino, alkylcarbonylamino, alkylamino or dialkylamino group; R4 signifies hydrogen, alkyl or alkylaryl group; X is CH2, O or S, and n is 1, 2 or 3, with the proviso that if X is CH2, n is not 1, and a method for their preparation. The compounds have potentially valuable pharmaceutical properties for the treatment of cardiovascular disorders such as hypertension and chronic heart failure.
摘要:
The invention concerns compounds of formula (I): R—A—R′ wherein: A is as defined in the description; R represents a group (V), (VI), (VII) or (VIII), where E, Q, R1, R2, R3, v and R4 are as defined in the description; R′ represents a —(CH2)t-R5 group wherein t and R5 are as defined in the description.
摘要:
The invention relates to substituted alcohol compounds of the formula (I): wherein X, R1, R2, R3, RN, R20 and RC are defined herein. The compounds are useful in the treatment or prevention of Alzheimer's disease and more specifically to compounds that are capable of inhibiting beta-secretase, an enzyme that cleaves amyloid precursor protein to produce amyloid beta peptide (A-beta), a major component of the amyloid plaques found in the brains of Alzheimer's sufferers.
摘要翻译:本发明涉及式(I)的取代醇化合物:其中X,R 1,R 2,R 3,R SUB > N,R 20和R C C在本文中定义。 这些化合物可用于治疗或预防阿尔茨海默氏病,更具体地可用于能够抑制β-分泌酶的化合物,该酶分解淀粉样蛋白前体蛋白以产生淀粉状蛋白β肽(A-β),其是淀粉样蛋白的主要成分 在阿尔茨海默病患者的大脑中发现的斑块。
摘要:
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, p, q, Ar, R1 and R2 are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I.
摘要:
There is provided compounds of formula I, wherein R1, R2, R3, Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
摘要:
Compounds of Formula 1 where X is S and the variables have the meaning defined in the specification are specific or selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors, and as such have no or only minimal cardivascular and/or sedatory activity. These compounds of Formula 1 are useful as medicaments in mammals, including humans, for treatment of diseases and or alleviations of conditions which are responsive to treatment by agonists of alpha2B adrenergic receptors. Compounds of Formula 1 where X is O also have the advantageous property that they have no or only minimal cardivascular and/or sedatory activity and are useful for treating pain and other conditions with no or only minimal cardivascular and/or sedatory activity.
摘要:
Substituted non-imidazole aryloxypiperidine compounds, compositions containing them, and methods of making and using them to treat or prevent histamine-mediated conditions.
摘要:
The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1–R7, X1, X2, R, Q, and n are as defined herein.
摘要翻译:本发明提供具有式(I)的化合物:另外提供其合成方法及其用于治疗癌症的方法,其中R 1 -R 7 X 1,X 2,R 3,Q 3和n如本文所定义。
摘要:
An object of the present invention is to produce and isolate a linear oligolactic acid thioester having a thioester group at the terminus as a single compound. According to the present invention, there is provided a compound represented by the formula (1) or a salt thereof: wherein X represents a hydrogen atom or a protective group for a hydroxyl group; Y represents an aliphatic group, an aryl group or a heterocyclic group; and n represents an integer of 0 to 19.
摘要:
The invention concerns compounds of formula (I): R—A—R′ wherein: A is as defined in the description; R represent, a group (V), wherein R′a and R″a are as defined in the description, or R forms with A a cyclic structure as defined in the description; R′ represents a (CH2)t—R2 group wherein q, t, and R2 are as defined in the description. The invention is useful for preparing medicines.